Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
All Resources Treatments A-Z Personal Assistant Help Center Crisis
Powered By
Real members of MyMyelomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

Next Generation m-RNA trials - sign up for developing MM vaccines

A MyMyelomaTeam Member asked a question 💭
Lee, MA

M-RNA disease treatment is such a cool and rapidly developing science. Moderna has multiple trials ongoing looking at the effectiveness of these treatments on multiple lines of cancer, with the goal of developing effective vaccines against aggressive cancers. The vaccines active the body’s own k-cells to recognize abnormal myeloma cells and tumors and kill them (even drug resistant ones). If this interests you as it does me, Phase 1 (dosing levels) and Phase 2 (testing response) is going on now.

… read more
August 28, 2025
 · 
Reactions
A MyMyelomaTeam Member

I have been on a clinical trial since 1-2-24 and am MRD Negative. I thank God and Fred Hutchison everyday for this opportunity.

August 28, 2025 (edited)
MyMyelomaTeam

Clinical trials are essential for developing new myeloma treatments, with many showing promising results. Recent trials have demonstrated significant advances in treating relapsed and hard-to-treat multiple myeloma, with some therapies achieving impressive response rates.

Before participating in any clinical trial, here Show Full Answer

Clinical trials are essential for developing new myeloma treatments, with many showing promising results. Recent trials have demonstrated significant advances in treating relapsed and hard-to-treat multiple myeloma, with some therapies achieving impressive response rates.

Before participating in any clinical trial, here are key benefits to consider:
• Access to cutting-edge treatments not otherwise available
• Enhanced care and monitoring from research teams
• Regular assessments and detailed follow-up
• Costs are typically covered by trial sponsors
• Opportunity to advance crucial myeloma research Recent clinical trials have shown encouraging outcomes. For example, new combination therapies have helped 82% of people with relapsed myeloma see their cancer shrink or disappear for extended periods. These trials are particularly important for those with relapsed or refractory multiple myeloma who haven't responded to standard treatments.

Remember to discuss participation with your healthcare team to understand if this specific trial aligns with your treatment journey.

August 28, 2025
A MyMyelomaTeam Member

Jamie, thanks for this information. I'm excluded because of my current treatments. I sure hope the trial gets excellent results.

August 28, 2025

Related Questions

View All

How many people contracted Multiple Myeloma since this Covid-19 pandemic started?

A MyMyelomaTeam Member asked a question 💭
Newfoundland, Canada
November 4, 2023

Has anyone ever had a double M Spike? Do you know what it means?

A MyMyelomaTeam Member asked a question 💭
April 18

What does the beginning of relapse feel like?

A MyMyelomaTeam Member asked a question 💭
Snyder, TX
June 22, 2025

Can Certain Medications Raise the Risk for Developing Myeloma?
What Is M Protein in Multiple Myeloma?
Participating in Clinical Trials for Multiple Myeloma: 4 Possible Benefits and 3 Risks
Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In